100
Participants
Start Date
February 28, 2015
Primary Completion Date
October 31, 2015
Study Completion Date
August 31, 2016
Tranexamic Acid
Tranexamic Acid Placebo
Rosuvastatin or matching placebo
Subjects who are not on a statin will also be randomized to Rosuvastatin or Rosuvastatin placebo. 40mg preoperatively, followed by 20mg postoperatively (4-6 hours after surgical close) and 20mg/day for 30 days postoperatively.
Hamilton General Hospital, Hamilton
Juravinski Hospital, Hamilton
Collaborators (1)
Population Health Research Institute
OTHER
Hamilton Health Sciences Corporation
OTHER
McMaster University
OTHER